Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

Similar articles for PubMed (Select 20571437)

1.

A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.

Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S.

J Clin Psychopharmacol. 2010 Aug;30(4):425-30. doi: 10.1097/JCP.0b013e3181e69042. Erratum in: J Clin Psychopharmacol. 2010 Oct;30(5):652.

PMID:
20571437
2.

Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.

Potkin SG, Weiden PJ, Loebel AD, Warrington LE, Watsky EJ, Siu CO.

Int J Neuropsychopharmacol. 2009 Oct;12(9):1233-48. doi: 10.1017/S1461145709000352. Epub 2009 May 7.

PMID:
19419595
3.

A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.

Hirsch SR, Kissling W, Bäuml J, Power A, O'Connor R.

J Clin Psychiatry. 2002 Jun;63(6):516-23.

PMID:
12088164
4.

Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol.

Harvey PD, Pappadopulos E, Lombardo I, Kremer CM.

Schizophr Res. 2009 Nov;115(1):24-9. doi: 10.1016/j.schres.2009.01.004. Epub 2009 Feb 3.

PMID:
19189878
5.

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

Olié JP, Spina E, Murray S, Yang R.

Int Clin Psychopharmacol. 2006 May;21(3):143-51.

PMID:
16528136
6.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
7.
8.

Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.

Breier A, Berg PH, Thakore JH, Naber D, Gattaz WF, Cavazzoni P, Walker DJ, Roychowdhury SM, Kane JM.

Am J Psychiatry. 2005 Oct;162(10):1879-87.

PMID:
16199834
9.

Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.

Citrome L, Yang R, Glue P, Karayal ON.

Schizophr Res. 2009 Jun;111(1-3):39-45. doi: 10.1016/j.schres.2009.03.009. Epub 2009 Apr 17.

PMID:
19375893
10.
11.
12.

Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

Weiden PJ, Simpson GM, Potkin SG, O'Sullivan RL.

J Clin Psychiatry. 2003 May;64(5):580-8.

PMID:
12755663
14.
15.

The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.

Garcia E, Robert M, Peris F, Nakamura H, Sato N, Terazawa Y.

CNS Drugs. 2009;23(7):615-25. doi: 10.2165/00023210-200923070-00006.

PMID:
19552488
16.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
17.

Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia.

Kane JM, Khanna S, Rajadhyaksha S, Giller E.

Int Clin Psychopharmacol. 2006 Jan;21(1):21-8.

PMID:
16317313
18.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
19.

Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.

Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT Jr.

Am J Psychiatry. 1998 Jun;155(6):751-60.

PMID:
9619146
20.

Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.

Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A.

Int J Geriatr Psychiatry. 2003 Nov;18(11):1013-20.

PMID:
14618553
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk